Emerging intervention of antidepressant with DMARD in non-cancerous nociceptive persistent pain associated depression in FCA induced rheumatoid arthritic rats
Rheumatoid arthritis (RA) is a chronic inflammatory disorder that causes pain, systemic complications and premature mortality. Depression has also been identified as a problem for persons with RA. This association remaining significant even after the degree of disease activity is controlled. In the...
Saved in:
Main Authors: | Sudhakar Pachiappan (Author), Sudaroli Murugaiyan (Author), Sabarinath Chandrasekar (Author) |
---|---|
Format: | Book |
Published: |
Universidade de São Paulo,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of immunomodulating treatment (usage of DMARDs) in rheumatoid arthritis on depression
by: Magdalena Kozyra, et al.
Published: (2020) -
Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity
by: Juthamas Prawjaeng, et al.
Published: (2023) -
Healthcare professionals' perceptions on barriers and facilitators to DMARD use in rheumatoid arthritis
by: M. J. H. Voshaar, et al.
Published: (2022) -
Using floating catchment area (FCA) metrics to predict health care utilization patterns
by: Paul L. Delamater, et al.
Published: (2019) -
Una nueva herramienta de evaluación basada en Filtros de Corrección Automática (FCA)
by: Vitturini, Mercedes, et al.
Published: (2011)